First Page | Document Content | |
---|---|---|
Date: 2015-06-12 10:36:45 | Targeting Notch/Delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) pathways by an anti-DLL4/Anti-VEGF bi-specific monoclonal antibody inhibits tumor growth and reduces cancer stem cell frequency inAdd to Reading ListSource URL: posters.omed.s3.amazonaws.comDownload Document from Source WebsiteFile Size: 650,01 KBShare Document on Facebook |